Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Braf genes" patented technology

Kit (BRAF gene detection kit for intestinal cancer)

ActiveCN310110921SIntestinal CancerBraf genes
1. The name of the design product: kit (BRAF intestinal cancer gene detection typing kit). 2. The use of the design product: the design product is used for packaging reagents. 3. The design points of the design product: the combination of shape and pattern. 4. The picture or photo that best indicates the design points: perspective view.
Owner:王红

Compound for regulating activity or expression of BRAF and uses therof

PCT designated stageWO2026079788A1Organic active ingredientsNervous disorderDiseaseBraf genes
The present invention relates to a compound for regulating the expression level and / or activity of the BRAF gene, and a composition comprising same. The compound and the composition are useful for preventing, treating, or alleviating BRAF-related diseases, disorders, and conditions.
Owner:SOVARGEN CO LTD

Construction of efficacy prediction model for patients with wild-type raf and braf gene colorectal liver metastasis based on radiomics features

ActiveCN114822824BInitial treatmentEfficacy
The present application belongs to the technical field of intelligent medical treatment, and particularly relates to a RAS, BRAF gene wild type colorectal cancer liver metastasis patient curative effect prediction model based on image group characteristics and application thereof. The present application successfully constructs a model for realizing curative effect prediction of RAS, BRAF gene wild type colorectal cancer liver metastasis patients receiving bevacizumab combined with chemotherapy treatment in the late first line based on CT image group characteristics before treatment: the enhanced CT image group data before initial treatment of patients with advanced colorectal cancer liver metastasis at the time of initial diagnosis is collected, 7 image group characteristics are obtained by using 1000 times Lasso-Logistic analysis, and an image group prediction model is constructed by using a multi-factor logistic regression method. The model constructed by the present application has important clinical application and popularization value from the clinical actual problem.
Owner:CHIMEDICAL UNIVERSITY

A marker detection reagent, kit and application for intestinal cancer gene mutation detection

PendingCN122128435AMicrobiological testing/measurementDNA/RNA fragmentationIntestinal CancerBraf genes
This invention, entitled "A Biomarker Detection Reagent, Kit, and Application for Colorectal Cancer Gene Mutation Detection," belongs to the field of biomedical technology. The technical problem to be solved is to provide a biomarker detection reagent capable of comprehensively detecting colorectal cancer gene mutations while ensuring high sensitivity and high specificity, thus addressing the difficulty in simultaneously achieving comprehensive site coverage, high sensitivity, high specificity, and high accuracy in existing technologies. The key technical solution is a biomarker detection reagent for colorectal cancer gene mutation detection, comprising a combination of amplification primers for detecting mutation sites in KRAS, NRAS, PIK3CA, and BRAF genes. The amplification primer combination includes primers for amplifying blocked mutation systems and ordinary primers.
Owner:BEIJING SINOMDGENE TECH CO LTD

Marker and kit for detecting gastric cancer, and use thereof

Provided is a methylation marker for gastric cancer detection. Provided are 28 differentially methylated regions (DMRs) for diagnosing or assisting with the diagnosis of cancer, and an ELMO1 gene and a KCNA3 gene with a better performance are selected from these 28 DMRs as preferred methylation markers for detecting gastric cancer. Provided is an accurate, simple and economical means for the early screening of gastric cancer, which can improve the detection rate of gastric cancer, particularly early gastric cancer, in gastric cancer high-risk populations and populations undergoing routine physical examinations, thereby improving the survival rate of gastric cancer patients, while saving on substantial medical expenses and alleviating the medical burden.
Owner:BGI GENOMICS CO LTD

Primer, probe, DNA template, kit and detection method for detecting human BRAF gene mutation

The invention belongs to the technical field of nucleic acid detection, and particularly relates to a primer, a probe, a DNA template, a kit and a detection method for detecting human BRAF gene mutation. According to the invention, a real-time fluorescent PCR amplification reaction system is established to realize rapid detection of BRAF gene mutation; the operation is simple and the result is easy to read. The amplification of the internal standard substance can monitor the accuracy and reliability of the whole detection process by synchronously amplifying a known amount of internal standard substance, so that the stability of experimental data is ensured; the device plays an irreplaceable role in the aspects of guaranteeing the detection quality and improving the detection efficiency.
Owner:SUZHOU HUAYIMEI BIOTECHNOLOGY CO LTD